Continuous monitoring with Reveal™ Insertable Cardiac Monitoring (ICM) is superior to standard medical care for AF detection in patients with a cryptogenic stroke1
As published in the New England Journal of Medicine
CLINICAL IMPACT: MORE APPROPRIATE CARE
Short-term cardiac monitoring is NOT sufficient for AF detection in cryptogenic stroke
- Extensive external monitoring found few patients with AF
- In the control group at 6 months, only 3 patients were found to have AF; yet there were 88 conventional ECGs, 20 24-hour Holters, and 1 event recorder used
- Reveal ICM detected over 7 times more patients with AF at the 12-month end point
- Sanna T, Diener HC, Passman RS, et al. Cryptogenic Stroke and Underlying Atrial Fibrillation (CRYSTAL AF). N Engl J Med. 2014; 370(26):2478-2486.